MAPK3 and major depressive disorder: In contrast, miR-15b has been found to augment cell apoptosis in Parkinson’s disease via targeting the GSK-3β/β-catenin signaling pathway, contribute to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens, deteriorate cardiomyocyte apoptosis in myocardial infarction via targeting Bcl-2/MAPK3, and contribute to extra-cellular matrix degradation in intervertebral disc degeneration via targeting SMAD3 [46,47,48,49].